GSK rejects three Unilever bids to buy consumer healthcare arm, says unit was “fundamentally undervalued”

Sunday, January 16, 2022 United Kingdom-based pharmaceutical giant GlaxoSmithKline (GSK) confirmed January 15 it had rejected three “unsolicited, conditional and non-binding proposals” by Unilever to acquire its Consumer Healthcare division, including one bid of GBP50 billion in value made on December 20, believing Unilever “fundamentally undervalued” the business and its potential. News that Unilever attempted […]

Read More
Posted in Uncategorized